As of 2024-09-09, the Relative Valuation of Karyopharm Therapeutics Inc (KPTI) is (18.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.73 USD, the upside of Karyopharm Therapeutics Inc based on Relative Valuation is -2598.5%.
The range of the Relative Valuation is (13.74) - (15.86) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.7x - 44.6x | 28.9x |
| Forward P/E multiples | 19.1x - 22.0x | 21.7x |
| Fair Price | (13.74) - (15.86) | (18.24) |
| Upside | -1982.3% - -2272.6% | -2598.5% |
| Date | P/E |
| 2024-09-06 | -1.01 |
| 2024-09-05 | -1.11 |
| 2024-09-04 | -0.99 |
| 2024-09-03 | -1.00 |
| 2024-08-30 | -1.05 |
| 2024-08-29 | -1.07 |
| 2024-08-28 | -1.08 |
| 2024-08-27 | -1.11 |
| 2024-08-26 | -1.14 |
| 2024-08-23 | -1.16 |
| 2024-08-22 | -1.09 |
| 2024-08-21 | -1.12 |
| 2024-08-20 | -1.10 |
| 2024-08-19 | -1.13 |
| 2024-08-16 | -1.13 |
| 2024-08-15 | -1.16 |
| 2024-08-14 | -1.12 |
| 2024-08-13 | -1.15 |
| 2024-08-12 | -1.13 |
| 2024-08-09 | -1.12 |
| 2024-08-08 | -1.16 |
| 2024-08-07 | -1.12 |
| 2024-08-06 | -1.16 |
| 2024-08-05 | -1.21 |
| 2024-08-02 | -1.23 |
| 2024-08-01 | -1.28 |
| 2024-07-31 | -1.37 |
| 2024-07-30 | -1.47 |
| 2024-07-29 | -1.43 |
| 2024-07-26 | -1.35 |
| 2024-07-25 | -1.33 |
| 2024-07-24 | -1.31 |
| 2024-07-23 | -1.28 |
| 2024-07-22 | -1.26 |
| 2024-07-19 | -1.23 |
| 2024-07-18 | -1.27 |
| 2024-07-17 | -1.36 |
| 2024-07-16 | -1.39 |
| 2024-07-15 | -1.34 |
| 2024-07-12 | -1.31 |
| 2024-07-11 | -1.33 |
| 2024-07-10 | -1.20 |
| 2024-07-09 | -1.17 |
| 2024-07-08 | -1.10 |
| 2024-07-05 | -1.14 |
| 2024-07-03 | -1.15 |
| 2024-07-02 | -1.11 |
| 2024-07-01 | -1.13 |
| 2024-06-28 | -1.20 |
| 2024-06-27 | -1.35 |